Fertility drug pergoveris tested in japanese and caucasian women
NCT ID NCT07269327
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This completed phase 1 study looked at how the fertility drug Pergoveris (a combination of two hormones, FSH and LH) is processed in the body of 24 healthy premenopausal women of Japanese or Caucasian origin. Participants took a birth control pill for about 4 weeks to suppress their natural hormones, then received a single injection of Pergoveris. The goal was to measure hormone levels in the blood and check for side effects, helping to guide future dosing in fertility treatments.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Pergoveris (follitropin alfa and lutropin alfa)
What this could lead to
If successful, this study could help doctors choose the right dose of Pergoveris for fertility treatments in women of different ethnic backgrounds.
What could go wrong
This is a very early, small study (24 healthy women) looking at drug levels, not actual fertility outcomes. Results may not apply to women with fertility issues or other ethnic groups.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FERTILITY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fortrea Clinical Research Unit Ltd
Leeds, United Kingdom